Ratcliffe Liam

Average Profitability
5.45%
Insider Buys Quantity
5
Insider Buys Sum
$108.37M
Insider Sells Quantity
18
Insider Sells Sum
$71.63M

Insider Activity of Ratcliffe Liam

The largest purchase of all time was on 2018-10-01 and amounted to 2000000 shares of Arvinas, Inc. for $32M.

The largest sale of all time was on 2021-12-14 and amounted to 156464 shares of Arvinas, Inc. for $10.3M.

Biography of Ratcliffe Liam

No biography is available at this moment.

2021-12-16SaleArvinas, Inc.
ARVN
director
85,705
0.1636%
$69.36$5.94M-27.43%
2021-12-15SaleArvinas, Inc.
ARVN
director
113,536
0.2076%
$66.81$7.58M-27.7%
2021-12-14SaleArvinas, Inc.
ARVN
director
156,464
0.2964%
$65.86$10.3M-23.78%
2021-11-15SaleArvinas, Inc.
ARVN
director
21,284
0.0412%
$84.87$1.81M-34.57%
2021-11-12SaleArvinas, Inc.
ARVN
director
39,869
0.076%
$84.94$3.39M-35.45%
2021-11-11SaleArvinas, Inc.
ARVN
director
59,799
0.114%
$86.23$5.16M-36.38%
2021-11-10SaleArvinas, Inc.
ARVN
director
13,358
0.0257%
$88.20$1.18M-37.28%
2021-11-09SaleArvinas, Inc.
ARVN
director
33,008
0.0626%
$91.97$3.04M-40.61%
2021-11-08SaleArvinas, Inc.
ARVN
director
81,054
0.1562%
$94.45$7.66M-41.06%
2021-11-05SaleArvinas, Inc.
ARVN
director
58,017
0.1098%
$91.61$5.31M-40.02%
2020-12-18PurchaseArvinas, Inc.
ARVN
director
285,714
0.6945%
$70.00$20M+16.03%
2020-03-03PurchasePassage Bio, Inc.
PASG
director
1.1M
5.6316%
$18.00$19.85M-5.13%
2019-11-12PurchaseArvinas, Inc.
ARVN
director
1.36M
3.4224%
$22.00$29.92M+33.94%
2018-10-01PurchaseArvinas, Inc.
ARVN
director
2M
6.4271%
$16.00$32M+24.92%
2018-04-03PurchaseCogent Biosciences, Inc.
COGT
director
550,000
0.6283%
$12.00$6.6M-3.49%
2013-09-27SaleArray Technologies, Inc.
ARRY
director
863,521
0.5072%
$5.99$5.17M
2013-09-26SaleArray Technologies, Inc.
ARRY
director
262,207
0.1549%
$6.02$1.58M
2013-09-16SaleArray Technologies, Inc.
ARRY
director
319,033
0.192%
$6.14$1.96M
2013-09-13SaleArray Technologies, Inc.
ARRY
director
546,660
0.3225%
$6.01$3.29M
2013-09-12SaleArray Technologies, Inc.
ARRY
director
807,479
0.4829%
$6.10$4.92M
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.